Your shopping cart is currently empty

Nav1.8-IN-7 (Example 116) serves as a selective inhibitor of Nav1.8, demonstrating more than 50% inhibition at 100 nM specifically for Nav1.8. It exhibits an IC50 of 15.6 μM for the hERG channel. This compound holds promise in the field of pain research [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Nav1.8-IN-7 (Example 116) serves as a selective inhibitor of Nav1.8, demonstrating more than 50% inhibition at 100 nM specifically for Nav1.8. It exhibits an IC50 of 15.6 μM for the hERG channel. This compound holds promise in the field of pain research [1]. |
| In vitro | Nav1.8-IN-9 (Example 116; 1 μM) exhibits inhibition rates of Nav1.1, Nav1.3, Nav1.4, Nav1.5, Nav1.6, and Nav1.7 of 1.2%, 3.7%, <1%, <1%, 2.6%, and <1%, respectively [1]. |
| In vivo | Pharmacokinetic Parameters of Nav1.8-IN-7 in male Sprague-Dawley rats [1]: PO (100 mg/kg), C_max (ng/mL) 2566, AUC_0-24 (ng/mL∗h) 42454, t_1/2 (h) 8.7." |
| Molecular Weight | 515.84 |
| Formula | C22H18ClF4N3O5 |
| Cas No. | 2761181-58-0 |
| Smiles | O(C1=C(C(NC=2C=C(OC[C@@H](CO)O)N=NC2)=O)C=C(Cl)C(C(F)(F)F)=C1)C3=C(C)C=C(F)C=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.